Effectiveness and management of ponatinib as second-line treatment in chronic myeloid leukemia: an analysis from the monitoring registries of the Italian medicines agency (AIFA).

Ann Hematol

Italian Medicines Agency, Rome, Italy.

Published: May 2023

Download full-text PDF	Source
http://dx.doi.org/10.1007/s00277-023-05168-8	DOI Listing

Publication Analysis

effectiveness management

management ponatinib

ponatinib second-line

second-line treatment

treatment chronic

chronic myeloid

myeloid leukemia

leukemia analysis

analysis monitoring

monitoring registries

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!